- Home
- ARMP vs GMGI Comparison
ARMP vs GMGI Comparison
Compare ARMP & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | GMGI |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.7M | 115.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ARMP | GMGI |
|---|---|---|
| Price | $6.42 | $0.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $12.00 | $4.00 |
| AVG Volume (30 Days) | 54.2K | ★ 222.2K |
| Earning Date | 03-19-2026 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,054,000.00 | ★ $179,142,103.00 |
| Revenue This Year | $4.48 | $25.59 |
| Revenue Next Year | N/A | $14.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 37.24 |
| 52 Week Low | $0.90 | $0.58 |
| 52 Week High | $16.34 | $2.50 |
Technical Indicators
Market Signals| Indicator | ARMP | GMGI |
|---|---|---|
| Relative Strength Index (RSI) | 51.52 | 47.97 |
| Support Level | $5.75 | $0.60 |
| Resistance Level | $6.37 | $0.78 |
| Average True Range (ATR) | 0.74 | 0.07 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 33.19 | 64.22 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.